表紙
市場調查報告書

微生物附著量測試市場 - 成長,趨勢及預測(2019年 - 2024年)

Bioburden Testing Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 871416
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
Back to Top
微生物附著量測試市場 - 成長,趨勢及預測(2019年 - 2024年) Bioburden Testing Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年05月01日內容資訊: 英文 114 Pages
簡介

本報告提供全球微生物附著量測試市場的相關調查,市場概況和成長要素、阻礙因素,各產品、列舉法、用途、地區的市場分析,競爭情形。主要企業的簡介等資訊彙整。

目錄

第1章 簡介

  • 研究成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 微生物污染造成的高頻率產品回收
    • 對生命科學的研究開發投資的增加
    • 對醫療設備及消耗品的嚴格進程內實驗的要求
  • 市場阻礙因素
    • 高成本的微生物計數設備
    • 熟練人員的不足
  • 波特五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業的競爭

第5章 市場區隔

  • 各產品
    • 消耗品
    • 設備
  • 各列舉法
    • 薄膜過濾
    • 平板計數法
    • 最確數(MPN)
    • 其他方法
  • 各用途
    • 原料檢驗
    • 醫療設備檢驗
    • 進程內檢驗
    • 設備的清洗檢驗
    • 其他的用途
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Becton, Dickinson and Company
    • Charles River Laboratories Inc.
    • Merck KGaA
    • Nelson Laboratories Inc.
    • Pacific BioLabs Inc.
    • SGS SA
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec Co. Ltd

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 64711

Market Overview

Bioburden testing is a process of measuring viable microorganisms on medical devices, raw material, or package. The process helps in determining parameters for its sterilization process to ensure safety and effectiveness of medical devices. It further aids in routine monitoring of raw material, components, and assembly processes in the manufacturing process. The bioburden testing is used for assessment of cleaning processes, and packaging of products to ensure safety. Growth in the medical devices, pharmaceutical, and rising product recalls due to microbial contamination are factors that drive the growth of the world bioburden testing market.

In biotechnology and food & beverage industries the safety concerns supplements growth. The presence of bacteria on the surface can affect the industry like pharmaceutical and other industry which is directly related to the human begins. Various regulation has been made to check all the parameter of safety and cleaning in the industry or their products. For instance, in the U.S the Title 21 is the code of federal regulation that covers the drugs and food for the FDA. Many other organizations are also having the code and standard parameter for monitoring.

Scope of the Report

As per the scope of the report, Bioburden Testing is an integral part of validation and revalidation of sterilization processes, assessment of the efficiency of cleaning processes, routine monitoring of manufacturing processes, monitoring of raw materials, components or packaging, and overall environmental monitoring programs.

Key Market Trends

Consumables are Expected to Hold Largest Share of Global Bioburden Testing Market, Over the forecast period

Consumables accounted for the largest market share in the global Bioburden Testing market due to the high requirement of kits and reagents whereas the instruments are the one-time investment. The long shelf life of the kits and reagents and the repeated purchase of media, kits, and reagents are driving the adoption of the bioburden testing consumables.

North America Region Holds the Largest Market Share of Bioburden Testing Market

North America was the largest regional market in terms of revenue. Sustained growth in pharmaceutical and biotechnology industries, the rising food and medicine safety concerns in general public, and a strong trend of R&D investments in life sciences, by both industry and academia, are the primary factors driving the growth of the market. Increasing government support for pharmaceutical and biotechnology companies is also impacting the growth of the market in North America.

Competitive Landscape

The Bioburden Testing Market consists of several major players. The companies are implementing certain strategic initiatives such as a merger, new product launch, acquisition and partnerships that help them in strengthening their market position. For instance, Charles River Laboratories is adopting innovative technology platform which is helping in streamline bioburden testing. Also, one of the players Merck KGaA., has the product for testing of bioburden name as EZ Fluo Rapid Detection, Ready-to-Use Culture Media for Bioburden Testing, and others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Frequency of Product Recall Due to Microbial Contamination
    • 4.2.2 Increasing R&D Investments in Life Sciences
    • 4.2.3 Stringent In-process Testing Requirements for Medical Devices and Consumables
  • 4.3 Market Restraints
    • 4.3.1 High Costs of Microbial Enumeration Instruments
    • 4.3.2 Lack of Skilled Personnel
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Products
    • 5.1.1 Consumables
      • 5.1.1.1 Culture Media and Reagents
      • 5.1.1.2 Other Consumables
    • 5.1.2 Instruments
      • 5.1.2.1 Automated Microbial Identification Systems
      • 5.1.2.2 Polymerase Chain Reaction (PCR) Systems
      • 5.1.2.3 Microscopes
      • 5.1.2.4 Other Instruments
  • 5.2 By Enumeration Method
    • 5.2.1 Membrane Filtration
    • 5.2.2 Plate Count Method
    • 5.2.3 Most Probable Number (MPN)
    • 5.2.4 Other Enumeration Methods
  • 5.3 By Application
    • 5.3.1 Raw Material Testing
    • 5.3.2 Medical Devices Testing
    • 5.3.3 In-process Testing
    • 5.3.4 Equipment Cleaning Validation
    • 5.3.5 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson and Company
    • 6.1.2 Charles River Laboratories Inc.
    • 6.1.3 Merck KGaA
    • 6.1.4 Nelson Laboratories Inc.
    • 6.1.5 Pacific BioLabs Inc.
    • 6.1.6 SGS SA
    • 6.1.7 Thermo Fisher Scientific Inc.
    • 6.1.8 WuXi AppTec Co. Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top